In this study, we observed elevated levels of plasma and cerebrospinal fluid (CSF) osteocalcin (OCN) in patients with preclinical Alzheimer's disease (AD), mild cognitive impairment, and AD dementia. This evidence concerns the gene BGLAP and Cognitive impairment.